Delivery Order SPE2DR25D1002-SPE2DR26FGN6T

The Defense Logistics Agency awarded a $1,790.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vial (5ML) on July 25, 2025, with an ultimate completion date of August 15, 2025. This is a non-set-aside contract, competitively awarded to support federal medical procurement needs. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office and primary distribution operations. This delivery...

The Defense Logistics Agency awarded a $3,354.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML Vial on November 17, 2025, with an ultimate completion date of December 9, 2025. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion...

The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,079.06 for HYPERRAB 300 Unit/ML Vial on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a small-value pharmaceutical procurement supporting federal...

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for HYPERRAB 300 Unit/ML Vial pharmaceutical product, with a ceiling value of $9,475.20. Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. The order is priced firm fixed price with no set-aside applied. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and holds a significant Indefinite Delivery Contract with DLA Troop Support Medical...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of HYPERRAB 300 Unit/ML vial in 5ML quantities, with a ceiling value of $8,668.70 and a completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...

The Defense Logistics Agency awarded a $8,668.70 delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL vial 5mL on December 12, 2025, with an ultimate completion date of January 6, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...

The Defense Logistics Agency awarded a $3,465.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of HYPERRAB 300 Unit/ML vials, with an ultimate completion date of October 6, 2025. This non-set-aside contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999...

The Defense Logistics Agency awarded a $3,465.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials, with an ultimate completion date of August 15, 2025. This non-set-aside competitive award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is to be fulfilled at AmerisourceBergen's corporate office location in...

The Defense Logistics Agency awarded a $26,006.10 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of HYPERRAB 300 Unit/mL Vial 5mL, a rabies immunoglobulin product. This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of January 12, 2026, and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This...

This delivery order, awarded on September 22, 2025, to AmerisourceBergen Drug Corp for $10,744.80, procures HYPERRAB 300 Unit/mL vials (5mL) for the Defense Logistics Agency's Medical Supply Chain. The award is non-competitive with no set-aside designation and carries a firm fixed-price structure with an ultimate completion date of October 14, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...